Wave Life Sciences fell 59.7% from $6.76 to $2.72, behind the S&P 500's +9.7%. Its worst day was Mar 26 (−49.6%), and its low came Nov 19 at $2.72.
Story events cover the past 12 months · Times ET
Nov 20, 2025 – Nov 19, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Wave Life Sciences closed at its highest level of the year, 215.5% above where the year started.
+15.1% · S&P 500 −0.1%
EPS of $-0.30 missed the $-0.27 estimate on $17.2M revenue (est. $14.2M).
+5.6% · S&P 500 −0.6%
Wave Life Sciences shares fell 49.6%, while the S&P 500 fell 1.8%.
−49.6%, the year's worst day · S&P 500 −1.8%
EPS of $-0.13 beat the $-0.32 estimate on $38.2M revenue (est. $8.5M).
+8.4% · S&P 500 −0.5%
EPS of $-0.34 missed the $-0.30 estimate on $2.3M revenue (est. $7.4M).
−0.9% · S&P 500 +1.7%
EPS of $-0.30 beat the $-0.33 estimate on $13.2M revenue (est. $4.1M).
+7.5% · S&P 500 +0.6%
Where it ended: a close of $2.72 on Nov 19, 2026. Up next: Q4 2026 earnings on Feb 25, 2027 (EPS est. $-0.32, revenue est. $9.5M).
Nothing in the past 12 months.
All WVE dividend history